This study is accepting new patients by invitation only

A Study of the Experimental PET/CT Radiotracer "18F-avb6-Binding-Peptide" After COVID-19 (Coronavirus) Infection

a study on COVID-19

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UC Davis
Dates
study started
estimated completion
Principal Investigator
by Julie L. Sutcliffe, Ph.D (ucdavis)

Description

Summary

This is a PET/CT study using the 18F-αvβ6-binding-peptide.The goal of this study is to evaluate this peptide in patients after infection with SARS CoV2.

Official Title

18F-αvβ6-binding-peptide PET/CT in Patients Post SARS CoV2 Infection

Details

The goal of the study is to to acquire 18F-αvβ6-BP PET/CT images in patients diagnosed with SARS CoV2 and to demonstrate the ability of 18F-αvβ6-BP to detect lung damage.

Keywords

COVID-19 SARS-CoV-2 Infection COVID-19; SARS-CoV2 infection Infection 18F-αvβ6-BP

Eligibility

You can join if…

Open to people ages 18 years and up

  • Men and women age ≥ 18 yrs
  • Diagnosed with SARS CoV2
  • Must have 2 sequential COVID negative tests prior to each scan
  • Must have no previous lung disease prior to SARS CoV2 infection
  • Lung image (Xray or CT) taken during infectious/ diagnosis period
  • Will sign the IRB-approved consent form
  • Able to remain motionless for up to 30-60 minutes per scan.

You CAN'T join if...

  • Life expectancy <3 mo
  • Women who are pregnant or breast-feeding
  • Patients who cannot undergo PET/CT scanning because of weight limits(>350lbs)
  • Lack of availability for follow-up assessments
  • Re-infection with SARS CoV2 between scan sessions
  • Other active infectious respiratory illness

Location

  • University of California Davis
    Sacramento California 95817 United States

Lead Scientist at UC Health

  • Julie L. Sutcliffe, Ph.D (ucdavis)
    Professor, Hematology and Oncology. Authored (or co-authored) 56 research publications.

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
University of California, Davis
ID
NCT04376593
Phase
Phase 1
Study Type
Interventional
Last Updated